Sign in

NCT06371755Recruiting

Bone Evaluation by Ultrasound Radiofrequency Echographic Multi Spectrometry (REMS) vs Dual X-ray Absorptiometry (DXA)

REMS Versus DXA for Bone Mineral Density (BMD) Evaluation

Source: ClinicalTrials.gov · Last updated 5 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Bone Density Evaluation by means of the Ultrasound Technology Named Radiofrequency Echographic Multi Spectrometry (REMS) in Comparison With DXA Technique. Clinical Center involved in the study:IRCCS Orthopedic institute Galeazzi - Sant'Ambrogio The clinical study will evaluate the intra- and inter-operator repeatability of the REMS,(Radiofrequency Echographic Multi Spectrometry) ultrasound diagnostic technology implemented in the EchoStation device (Echolight Spa, Lecce) and the diagnostic accuracy in comparison with DXA (used as standard reference).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
296 (estimated)
First submitted
8 Mar 2024
Start date
19 Nov 2019
Primary completion date
31 Dec 2025
Lead sponsor
Paola Pisani
Diseases
Osteoporosis
NCT number
NCT06371755

What you commit to

  • Study type: Interventional
  • Planned participants: 296
  • From 19 Nov 2019 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • age below 30 years or over 80 years,

Other

  • Male sex,
  • severe walking difficulties,
  • severe obesity (BMI \> 40 kg/m2),
  • declared pregnancy.

Who the study is looking for

  • patients scheduled for lumbar and/or femoral DXA examination,
  • female sex,
  • age range 30-80 years (for repeatability study), age range 50-70 years (for accuracy study),
  • absence of severe obesity (BMI \< 40 kg/m2),
  • absence of severe walking difficulties,
  • cognitive underwriting of informed consent.

Age in the registry: 30 years to 80 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio
Coordinator of this site? Confirm its status
MilanItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.